Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
Clinical trial NCT04045795 · COMPLETED
Trial details
- NCT number
- NCT04045795
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2024-03-27
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.